Achievements
-
.18,000health-care workers
across 2,082 health-care facilities trained to administer injectable artesunate for severe malaria
-
.Single-dosetafenoquine
for relapse prevention of P. vivax malaria approved by the US FDA
-
.Over 230Pathogen Boxes
shipped free of charge to scientists around the world to boost drug discovery for neglected diseases
Defeating malaria together
Featured resources
-
The life-saving benefits of pre-referral management
Apr 2019 -
Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum
Apr 2019 -
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker
Apr 2019
Events
-
12May
Wellcome Centre for Anti-Infectives Research Conference 2019
12-15 May 2019University of Dundee, UK -
24May
Celebrating a 10 year collaboration in malaria drug discovery
24 May 2019Cape Town, South Africa -
26Jun
7th International Conference on Plasmodium vivax Research (ICPvR)
26-28 JuneParis, France